Delivery Order SPE2DB22D3301-SPE2DB24FY1EP
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of 4,563,482,111 units of Rosuvastatin Calcium 20 mg tablets in 500-count bottles, with a firm fixed price of $6,400.32 and a completion date of January 31, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, to provide Rosuvastatin Calcium 40 mg tablets. The award has a potential value of $19,276.02 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Rosuvastatin Calcium 5 mg tablets in 1,000 count packages. The contract has a ceiling value of $11,596.99 and a period of performance through April 5, 2024. This delivery order is issued under an existing $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the...
- The Defense Logistics Agency Troop Support Medical awarded a $16,700 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562087658 ROSUVASTATIN CALCIUM 40 MG TAB 30S. As the parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location from September 7-8, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D3011|SPE2DB24FQ0FC) to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $35,103.25 contract is for the supply of 500 units of Rosuvastatin Calcium 5 mg tablets. This delivery order falls under AmerisourceBergen's existing indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 2025. AmerisourceBergen, a for-profit organization, serves...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $186,371.64 to Amerisourcebergen Drug Corporation for the supply of 500 units of Rosuvastatin Calcium 40mg tablets. Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 under the terms of the contract. As a leading provider of drug distribution and related services, Amerisourcebergen will utilize its extensive logistics network and supply chain...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $148,758.81 delivery order contract is for the supply of Rosuvastatin Calcium 40 mg tablets to support military healthcare programs. The contract has a performance period through January 31, 2024 and uses a firm fixed price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of 500 units of Rosuvastatin Calcium 5 mg tablets. The award has a ceiling value of $23,241.90 and a completion date of February 26, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $8,691.99 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 4561327196 Rosuvastatin Calcium 40 MG TAB 500S. The order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle and is to be performed in Conshohocken, Pennsylvania by June 26, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested generic cholesterol...
- The Defense Logistics Agency awarded a $2,721.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for 4561428014, Rosuvastatin Calcium 40 mg tablets in 500 count bottles. As the parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation will perform the contract through its Amerisourcebergen Division operating unit, with performance taking place in Conshohocken, Pennsylvania over a period of July 7-10, 2023. No subcontractors...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1EPDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ROSUVASTATIN CALCIUM 40 MG TAB 500S. The contract has a potential value of $16,652.31 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which enables Amerisourcebergen Drug Corp to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide in support of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 2/21/24 |